Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT04790175

Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH

Conditions: Antidiuretic Hormone, Inappropriate Secretion

Sex: All

Healthy volunteers: No

Enrollment: 300

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Location: Pharmacovigilance Department Osaka Osaka

Summary

The purpose of this study is to confirm the safety of tolvaptan in patients with hyponatremia in syndrome of inappropriate antidiuretic hormone secretion (SIADH) in Japan

Eligibility Criteria

Inclusion Criteria: * Subjects with a definite diagnosis of SIADH in reference to "Diagnostic and Treatment Manual of the Hypersecretion of Vasopressin (SIADH), Revised in 2018" Exclusion Criteria: \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04790175). StuddyBuddy aggregates publicly available trial information.